Abstract
52-Week Open-Label Safety and Tolerability Trial of Centanafadine Sustained Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have